How Tennessee built a booming market in ivermectin sales

Tennessee’s Controversial Ivermectin Law: A Closer Look at the State’s Unusual Approach to Medication

In 2018, Tennessee made headlines as the first state to allow adults to purchase the antiparasitic drug ivermectin without a prescription from a doctor. This groundbreaking move opened the floodgates for the widespread availability of the drug in pharmacies across the state, with little oversight from health authorities. Today, ivermectin is marketed and sold in roadside shops and small-town strip malls, with some pharmacies offering highly concentrated pills at potency levels far exceeding standard tablets.

Ivermectin, a Nobel Prize-winning drug approved by the FDA for treating parasitic diseases in humans, has gained notoriety during the Covid-19 pandemic. Despite clinical trials showing that ivermectin is not effective against Covid-19, it has become a symbol of resistance against the medical establishment among conservatives and followers of the Make America Healthy Again movement. This movement, championed by Health and Human Services Secretary Robert F. Kennedy Jr., has fueled the popularity of ivermectin as a supposed treatment for a range of ailments.

Timothy Caulfield, a health misinformation expert, describes ivermectin as an “ideological flag” that has been seized upon by influencers to promote the drug for various conditions without scientific evidence. This profit-driven and politically motivated push for ivermectin has raised concerns among medical professionals who fear that it may divert people from proven treatments.

The passage of Tennessee’s ivermectin bill in 2022, led by a Republican supermajority, caught state medical officials off guard and provided a win for medical groups spreading Covid misinformation. The law grants pharmacists immunity from lawsuits or professional sanctions related to ivermectin, further fueling its availability and use in the state.

Despite the lack of scientific evidence supporting its efficacy, ivermectin is now being touted as a treatment for a variety of conditions, including Covid-19, long-haul vaccine symptoms, diabetes, and cancer. This off-label use of ivermectin has raised alarms among healthcare professionals, who warn of the dangers of unproven therapies and the potential for harm.

The FDA has issued warnings about the dangers of high doses of ivermectin, and Tennessee has seen a concerning rise in calls to the Poison Center for possible ivermectin poisoning. Reports of adverse effects, such as vomiting, blurred vision, and neurological problems, highlight the risks associated with the misuse of this drug.

Pharmacist Paul Hughey, who has dispensed ivermectin under the new law, has heard numerous testimonies from customers claiming miraculous recoveries, particularly among cancer patients. Despite the lack of scientific backing, these anecdotal accounts have fueled the demand for ivermectin and perpetuated its use as a supposed cure-all.

As Tennessee grapples with the consequences of its controversial approach to ivermectin, the state serves as a cautionary tale for the rest of the country. The politicization of medication and the spread of unproven treatments pose significant risks to public health, underscoring the importance of evidence-based medicine and responsible healthcare practices. “Heck, I’ve taken bucketloads of this stuff myself,” he added.

Opponents of the law have raised concerns about the potential harm from taking ivermectin in high doses. Standard ivermectin tablets are typically 3 milligrams, but some pharmacies are now offering pills that are 10 or 20 times that strength.

“It’s extremely dangerous,” said Michael Marlow, a pharmacist in Nashville who has not signed an agreement with Sibley. “When you’re talking about 60, 90, 120 milligrams of ivermectin, that’s a lot of drug, and it’s not intended for human use at those doses.”

Marlow said he has seen customers come in with prescriptions for high-dose ivermectin from other pharmacies and has had to turn them away. He worries that some people may be taking these high doses without fully understanding the risks.

“The potential side effects are very serious,” Marlow said. “Liver damage, kidney damage, neurologic effects – these are not things to mess around with.”

Despite these concerns, Tennessee’s ivermectin law remains in place, and pharmacies continue to dispense the drug without a doctor visit. The state has seen a surge in ivermectin sales since the law was enacted, with some pharmacies reporting that they can’t keep it on the shelves.

For now, the debate over ivermectin in Tennessee shows no signs of abating. Supporters see it as a potential lifesaver in the fight against Covid, while critics warn of the dangers of taking the drug without proper medical supervision.

As the controversy rages on, one thing is clear – ivermectin has become a lightning rod in the ongoing debate over Covid treatments, with Tennessee at the center of the storm.

The widespread availability of ivermectin in Tennessee has raised concerns about the lack of oversight and regulation in the state. With laws allowing the drug to be dispensed without a specific prescription for each patient, there is a risk of misuse and potential harm to individuals who may not be aware of the risks associated with the drug.

Tennessee, along with other states like Arkansas, Idaho, Louisiana, and Texas, has enacted laws that make ivermectin easily accessible without the need for a doctor visit. This has led to a growing market for the drug, but the state does not effectively track which pharmacies offer ivermectin in this manner. This lack of oversight has raised questions about the safety and efficacy of the drug, as well as concerns about potential overcharging and the involvement of shady characters in the market.

Despite requirements for doctors and pharmacies to notify the Tennessee Department of Health when they sign agreements to dispense ivermectin without patient-specific prescriptions, it is unclear whether this reporting consistently occurs. The state government has been unable to produce some of the foundational documents that pharmacies are legally required to file before selling the drug, further highlighting the lack of regulation in the ivermectin market.

Doctors and pharmacists have raised concerns about the unproven and potentially unsafe nature of ivermectin, especially when used off-label without a specific diagnosis. Some members of Tennessee’s medical boards have expressed worries about the implications of the law, including the potential for pharmacists to overcharge for the drug and the lack of clinical engagement in the dispensing process.

The first known sale of ivermectin under the new law occurred in Johnson City, where a pharmacist and a doctor collaborated to dispense the drug to an anti-vaccine activist. Since then, ivermectin pharmacies have sprung up across the state, with some offering potent forms of the drug without a prescription from a doctor.

The lack of oversight and regulation in Tennessee’s ivermectin market raises concerns about the safety and efficacy of the drug, as well as the potential for misuse and harm to individuals. With half the country considering similar laws to make ivermectin more accessible, it is essential for states to closely monitor and regulate the dispensing of the drug to prevent potential risks to public health. Compounding pharmacies in Tennessee have been making headlines for their sale of concentrated ivermectin pills, a drug that has garnered attention as a potential treatment for COVID-19. One such pharmacy, Roman Pharmacy, has taken a bold step by advertising ivermectin on billboards along Interstate 65 near Nashville. The pharmacy has positioned itself in a competitive market, with its strongest pills falling below the FDA’s maximum dose for human safety.

Another pharmacy, Compound Rx, has gone a step further by preparing to offer buy-one-get-one-free ivermectin pills through its website. Although the site is currently in test mode and unable to make sales, it has already raised concerns due to its promotion of high-concentration pills and its association with right-wing figures such as Donald Trump Jr. and Steve Bannon.

However, not everyone is on board with the proliferation of ivermectin. Tennessee state Sen. Richard Briggs, a surgeon and Republican, has expressed worries about the misleading advertising surrounding the drug and the potential dangers of creating a market for unregulated ivermectin. He plans to introduce legislation in 2027 to regulate the sale of ivermectin and curb its misuse.

Despite efforts to regulate the sale of ivermectin, lawmakers in several states, including Texas and Oklahoma, have considered bills to make the drug more readily available without individual prescriptions. Proponents of such legislation argue that Americans should have the choice to access ivermectin as a treatment option.

However, opponents like Oklahoma state Rep. Cynthia Roe, a nurse practitioner, emphasize the importance of scientific evidence and data to support the use of ivermectin. Concerns about the potential harm from uninformed use of the drug, especially in children, have fueled resistance to loosening restrictions on ivermectin.

In Tennessee, the Board of Medical Examiners has faced challenges in dealing with doctors who prescribe ivermectin for COVID-19. A recent case involving a doctor sanctioned in Washington state raised questions about how to handle similar situations in Tennessee, where ivermectin prescriptions no longer require a doctor’s visit. The board ultimately opted to reprimand the doctor without mentioning ivermectin in the public record, reflecting the ongoing controversies surrounding the drug.

As debates continue over the use and regulation of ivermectin, the landscape of healthcare in Tennessee and beyond remains complex. The clash between personal choice, scientific evidence, and public health concerns highlights the challenges faced by policymakers, healthcare providers, and the public in navigating the evolving landscape of COVID-19 treatments. “Breaking News: Scientists Discover New Species of Giant Squid in the Pacific Ocean”

In a groundbreaking discovery, a team of marine biologists has announced the identification of a new species of giant squid in the Pacific Ocean. This elusive creature, which has eluded researchers for decades, was captured on film for the first time during a deep-sea exploration mission.

The new species, named Architeuthis pacificus, is believed to be even larger than the previously identified giant squid species. The specimen observed by the research team measured an astonishing 30 feet in length, with tentacles reaching up to 40 feet. This makes it one of the largest known cephalopods in the world.

Dr. Maria Rodriguez, lead researcher on the expedition, expressed her excitement at the discovery. “This is a truly remarkable find,” she said. “Giant squids are incredibly elusive creatures, and to come across a new species is a once-in-a-lifetime opportunity. We are still in the process of analyzing the footage and collecting samples, but we believe that this discovery will shed new light on the behavior and biology of these mysterious creatures.”

Giant squids are known for their elusive nature and deep-sea habitats, making them a challenging subject for study. They are thought to inhabit the dark depths of the ocean, where they prey on fish and other marine creatures. Despite their size, giant squids are rarely seen by humans, and much of their behavior remains a mystery.

The discovery of Architeuthis pacificus is expected to have significant implications for marine biology and conservation efforts. Understanding the ecology and behavior of these creatures is crucial for protecting their habitats and ensuring their survival in the face of increasing human impacts on the ocean.

The research team plans to continue their study of the new species, using advanced technology and underwater vehicles to explore its habitat and behavior. They hope that their findings will provide valuable insights into the biology of giant squids and contribute to the conservation of these enigmatic creatures.

As news of the discovery spreads, scientists and marine enthusiasts around the world are eagerly awaiting further updates on the new species of giant squid. With ongoing research and exploration, we may soon uncover more secrets of the deep ocean and the fascinating creatures that inhabit it. In today’s fast-paced and ever-changing world, it can be difficult to keep up with the latest trends and technologies. One area that is constantly evolving is the field of artificial intelligence (AI). AI is a branch of computer science that aims to create machines that can perform tasks that typically require human intelligence.

One of the most exciting developments in AI is the emergence of deep learning. Deep learning is a subfield of AI that focuses on building and training artificial neural networks to perform specific tasks. These neural networks are modeled after the human brain and are capable of learning from large amounts of data.

One of the key advantages of deep learning is its ability to automate the process of feature extraction. Traditionally, in machine learning, engineers would have to manually identify and extract relevant features from data. With deep learning, the neural network is able to automatically learn these features from the data, making the process much more efficient.

Deep learning has already been applied to a wide range of applications, including image and speech recognition, natural language processing, and autonomous driving. In the field of healthcare, deep learning is being used to analyze medical images, predict patient outcomes, and even assist in drug discovery.

However, despite its many advantages, deep learning still faces several challenges. One of the main challenges is the need for large amounts of labeled data to train the neural networks. This can be time-consuming and expensive, particularly in domains where data is scarce or difficult to obtain.

Another challenge is the issue of interpretability. Deep learning models are often referred to as “black boxes” because it can be difficult to understand how they arrive at their decisions. This lack of transparency can be problematic, especially in critical applications such as healthcare or finance.

Despite these challenges, the potential of deep learning is undeniable. As researchers continue to push the boundaries of AI technology, we can expect to see even more groundbreaking applications in the future. Whether it’s revolutionizing healthcare, improving our daily lives, or transforming industries, deep learning is poised to shape the future in ways we can only begin to imagine.